The content on this site is intended for healthcare professionals only
Mobile supportive care for children and young adults with ALL
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria
10 Nov 2021
Post-HSCT management of paediatric patients with ALL
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria
10 Nov 2021
Immunotherapy of T-ALL: Opportunities and hurdles
Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA
10 Nov 2021
Workshop diagnostics procedures in ALL
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
10 Nov 2021
Practical applications on new data of genetic ALL subtypes
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
10 Nov 2021
Triple class refractory multiple myeloma
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
10 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
29 Oct 2021
Minimum residual disease techniques in myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
29 Oct 2021
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore
29 Oct 2021
High-risk SMM imaging and NDMM treatment
Dr Elena Zamagni - University of Bologna, Bologna, Italy
28 Oct 2021
Rescue after daratumumab failure
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
26 Oct 2021
MRD-driven strategies and novel immunotherapies for multiple myeloma
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
25 Oct 2021